help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C. H.
Right arrow Articles by Demay, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C. H.
Right arrow Articles by Demay, M. B.
Endocrinology Vol. 142, No. 12 5386
Copyright © 2001 by The Endocrine Society


PTH-CALCITONIN-VITAMIN D-BONE

Targeting Expression of the Human Vitamin D Receptor to the Keratinocytes of Vitamin D Receptor Null Mice Prevents Alopecia

Cindy H. Chen, Yoshiyuki Sakai and Marie B. Demay

Endocrine Unit, Massachussetts General Hospital and Harvard Medical School, Boston MA

Vitamin D receptor (VDR) null mice develop hypocalcemia, hyperparathyroidism, rickets, osteomalacia and alopecia. Normalization of mineral ion homeostasis prevents all of these abnormalities except alopecia. Hair reconstitution assays, performed in athymic nude mice, demonstrate that the lack of VDR in keratinocytes leads to a defect in anagen initiation, similar to that observed in VDR null mice. Although these studies demonstrate that expression of the VDR in keratinocytes is necessary, they do not prove that it is sufficient for maintenance of the normal hair cycle. To address this hypothesis, we generated transgenic mice expressing the human VDR under the control of the keratin 14 (K14) promoter. Two highly expressing transgenic lines were mated with VDR null mice to obtain VDR null mice expressing the human VDR transgene (hVDR+/mVDR-). Expression of the transgene in the VDR null mice prevented alopecia. Furthermore, when subjected to anagen initiation, the hair follicle keratinocytes of the hVDR+/mVDR- mice demonstrated an enhanced proliferative response compared to those of control littermates. Restoration of VDR expression in the keratinocytes of VDR null mice, prevents the hair cycle defect that leads to the development of alopecia.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Endocr. Rev., October 1, 2008; 29(6): 726 - 776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, P. J. Malloy, and D. Feldman
Interactions of the Vitamin D Receptor with the Corepressor Hairless: ANALYSIS OF HAIRLESS MUTANTS IN ATRICHIA WITH PAPULAR LESIONS
J. Biol. Chem., August 31, 2007; 282(35): 25231 - 25239.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Cianferotti, M. Cox, K. Skorija, and M. B. Demay
Vitamin D receptor is essential for normal keratinocyte stem cell function
PNAS, May 29, 2007; 104(22): 9428 - 9433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. I. Ellison, R. L. Eckert, and P. N. MacDonald
Evidence for 1,25-Dihydroxyvitamin D3-independent Transactivation by the Vitamin D Receptor: UNCOUPLING THE RECEPTOR AND LIGAND IN KERATINOCYTES
J. Biol. Chem., April 13, 2007; 282(15): 10953 - 10962.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Xie, S. Chang, Y. Oda, and D. D. Bikle
Hairless Suppresses Vitamin D Receptor Transactivation in Human Keratinocytes
Endocrinology, January 1, 2006; 147(1): 314 - 323.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. Nagpal, S. Na, and R. Rathnachalam
Noncalcemic Actions of Vitamin D Receptor Ligands
Endocr. Rev., August 1, 2005; 26(5): 662 - 687.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Skorija, M. Cox, J. M. Sisk, D. R. Dowd, P. N. MacDonald, C. C. Thompson, and M. B. Demay
Ligand-Independent Actions of the Vitamin D Receptor Maintain Hair Follicle Homeostasis
Mol. Endocrinol., April 1, 2005; 19(4): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. M. Zinser and J. Welsh
Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice
Carcinogenesis, December 1, 2004; 25(12): 2361 - 2372.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. C. Fleet
Rapid, Membrane-Initiated Actions of 1,25 Dihydroxyvitamin D: What Are They and What Do They Mean?
J. Nutr., December 1, 2004; 134(12): 3215 - 3218.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Demay
Muscle: A Nontraditional 1,25-Dihydroxyvitamin D Target Tissue Exhibiting Classic Hormone-Dependent Vitamin D Receptor Actions
Endocrinology, December 1, 2003; 144(12): 5135 - 5137.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Gurlek, M. R. Pittelkow, and R. Kumar
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation
Endocr. Rev., December 1, 2002; 23(6): 763 - 786.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Vegesna, J. O'Kelly, M. Uskokovic, J. Said, N. Lemp, T. Saitoh, T. Ikezoe, L. Binderup, and H. P. Koeffler
Vitamin D3 Analogs Stimulate Hair Growth in Nude Mice
Endocrinology, November 1, 2002; 143(11): 4389 - 4396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society